Skip to content

Efficacy and safety of peroperative oral/exogenous indomethacin for pain prognosis in patients undergoing knee arthroplasty

Efficacy and safety of peroperative oral/exogenous indomethacin for pain prognosis in patients undergoing knee arthroplasty

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002666
Enrollment
Unknown
Registered
2019-10-13
Start date
2019-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Preoperative diagnosis of simple knee osteoarthritis; 2. Aged between 40-75 years; 3. Regular review as required, with good compliance and ability to cooperate with the research of the subject.

Exclusion criteria

Exclusion criteria: 1. With abnormal physical deformity, ligament injury around the knee joint, abnormal muscle strength and other abnormal physical factors; 2. Combined with tumor or systemic metabolic disease; 3. Long-term use of hormones; 4. Non-steroidal drugs were used 1 week before surgery; 5. Other treatments were used during treatment; 6. Suspected of a systemic or local infection; 7. The condition is critical and may be exacerbated by the inclusion of observations; 8. Those who are allergic to non-steroidal anti-inflammatory drugs; 9. All patients at risk of bleeding, eg. previous gastrointestinal bleeding or peptic ulcer. 10. Cannot make an accurate assessment of the effectiveness and safety of the drug; 11. Patients with diabetes or patients with skin lesions or skin diseases. 12. Other traumatic diseases were found during follow-up.

Design outcomes

Primary

MeasureTime frame
Postoperatively 3 days (post-op D1/2/3), 3 groups of patients with resting pain and active pain in the knee: using VAS score;

Secondary

MeasureTime frame
1 week postoperatively, comparison of knee function scores in 3 groups: HSS score;Differences in drug concentration between blood, knee joint fluid, subcutaneous tissue and deep tissue indomethacin in the three groups on the day of surgery;

Countries

China

Contacts

Public ContactXuewei Cao

Guangdong Provincial Hospital of Traditional Chinese Medicine

caoxuewei@126.com+86 13580516689

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026